Clinical Characteristics and Genetic Markers of Patients With MSI
| Patient No. . | Clinical Stage . | Sex/Age (yr) . | Diagnosis . | Cytogenetics and Molecular Genetics . | Treatment . |
|---|---|---|---|---|---|
| 213 | Relapse | M/34 | AML M1 | ND | CT |
| 702 | Diagnosis | F/55 | AML M2 | t(8;21); −X | NT |
| 739 | Diagnosis | M/35 | AML M3 | t(15;17) | NT |
| 32 | Diagnosis | F/44 | Pre-B ALL | 46, XX | NT |
| 63 | Relapse | M/38 | Pre-B ALL | 46, XY | CT |
| 74 | Relapse | M/52 | B ALL | ND | CT |
| 509 | Diagnosis | M/21 | T ALL | t (10; 14) (q24; q11); t (3; 9) (p13-14; p22-24) | NT |
| 619 | Diagnosis | F/43 | B ALL | ND | NT |
| VR5 | Diagnosis | M/41 | T ALL | 46, XY; 47, XY, del(4)(p14) | NT |
| 11 | Diagnosis | M/68 | Diffuse large B-cell lymphoma | bcl-2 rearrangement | NT |
| 52 | Relapse | M/45 | Follicle center lymphoma | bcl-2 rearrangement | CT |
| 23 | Diagnosis | F/72 | Follicle center lymphoma | bcl-2 rearrangement | NT |
| 298 | Relapse | F/79 | Mantle cell lymphoma | bcl-2 rearrangement | CT |
| Patient No. . | Clinical Stage . | Sex/Age (yr) . | Diagnosis . | Cytogenetics and Molecular Genetics . | Treatment . |
|---|---|---|---|---|---|
| 213 | Relapse | M/34 | AML M1 | ND | CT |
| 702 | Diagnosis | F/55 | AML M2 | t(8;21); −X | NT |
| 739 | Diagnosis | M/35 | AML M3 | t(15;17) | NT |
| 32 | Diagnosis | F/44 | Pre-B ALL | 46, XX | NT |
| 63 | Relapse | M/38 | Pre-B ALL | 46, XY | CT |
| 74 | Relapse | M/52 | B ALL | ND | CT |
| 509 | Diagnosis | M/21 | T ALL | t (10; 14) (q24; q11); t (3; 9) (p13-14; p22-24) | NT |
| 619 | Diagnosis | F/43 | B ALL | ND | NT |
| VR5 | Diagnosis | M/41 | T ALL | 46, XY; 47, XY, del(4)(p14) | NT |
| 11 | Diagnosis | M/68 | Diffuse large B-cell lymphoma | bcl-2 rearrangement | NT |
| 52 | Relapse | M/45 | Follicle center lymphoma | bcl-2 rearrangement | CT |
| 23 | Diagnosis | F/72 | Follicle center lymphoma | bcl-2 rearrangement | NT |
| 298 | Relapse | F/79 | Mantle cell lymphoma | bcl-2 rearrangement | CT |
Abbreviations: M, male; F, female; AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; CT, chemotherapy; NT, no treatment; ND, not determined.